NO950432D0 - Stereoselektiv syntese av nukleosidanaloger ved anvendelse av bicykliske mellomprodukter - Google Patents

Stereoselektiv syntese av nukleosidanaloger ved anvendelse av bicykliske mellomprodukter

Info

Publication number
NO950432D0
NO950432D0 NO950432A NO950432A NO950432D0 NO 950432 D0 NO950432 D0 NO 950432D0 NO 950432 A NO950432 A NO 950432A NO 950432 A NO950432 A NO 950432A NO 950432 D0 NO950432 D0 NO 950432D0
Authority
NO
Norway
Prior art keywords
pct
formula
image
nucleoside analogs
stereoselective synthesis
Prior art date
Application number
NO950432A
Other languages
English (en)
Other versions
NO303449B1 (no
NO950432L (no
Inventor
Tarek S Mansour
Colleen A Evans
Haolun Jin
Arshad M Siddiqui
Alan H L Tse
Original Assignee
Iaf Biochem Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iaf Biochem Int filed Critical Iaf Biochem Int
Publication of NO950432D0 publication Critical patent/NO950432D0/no
Publication of NO950432L publication Critical patent/NO950432L/no
Publication of NO303449B1 publication Critical patent/NO303449B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO950432A 1993-06-07 1995-02-06 Stereoselektiv syntese av nukleosidanaloger samt bicyklisk forbindelse NO303449B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939311709A GB9311709D0 (en) 1993-06-07 1993-06-07 Stereoselective synthesis of nucleoside analogues using bicycle intermediate
PCT/CA1994/000311 WO1994029301A1 (en) 1993-06-07 1994-06-07 Stereoselective synthesis of nucleoside analogues using bicyclic intermediate

Publications (3)

Publication Number Publication Date
NO950432D0 true NO950432D0 (no) 1995-02-06
NO950432L NO950432L (no) 1995-03-13
NO303449B1 NO303449B1 (no) 1998-07-13

Family

ID=10736757

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950432A NO303449B1 (no) 1993-06-07 1995-02-06 Stereoselektiv syntese av nukleosidanaloger samt bicyklisk forbindelse

Country Status (22)

Country Link
US (1) US5763606A (no)
EP (1) EP0654031B1 (no)
JP (1) JP3110461B2 (no)
KR (1) KR100304072B1 (no)
CN (1) CN1046720C (no)
AT (1) ATE188215T1 (no)
AU (1) AU668829B2 (no)
BR (1) BR9405423A (no)
CA (1) CA2141029C (no)
DE (1) DE69422374T2 (no)
DK (1) DK0654031T3 (no)
ES (1) ES2139744T3 (no)
FI (1) FI112078B (no)
GB (1) GB9311709D0 (no)
HK (1) HK1008673A1 (no)
HU (1) HU219199B (no)
NO (1) NO303449B1 (no)
NZ (1) NZ267379A (no)
OA (1) OA10349A (no)
PL (1) PL180870B1 (no)
RU (1) RU2139870C1 (no)
WO (1) WO1994029301A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684164A (en) * 1988-04-11 1997-11-04 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
WO1996012716A1 (en) * 1994-10-22 1996-05-02 Chong Kun Dang Corp. Nucleoside derivatives and process for preparing thereof
JP4249393B2 (ja) 1998-08-12 2009-04-02 トライアングル・ファーマシューティカルズ，インコーポレイテッド １，３−オキサチオランヌクレオチドの製造方法
US6979561B1 (en) 1998-10-09 2005-12-27 Gilead Sciences, Inc. Non-homogeneous systems for the resolution of enantiomeric mixtures
CA2308559C (en) 2000-05-16 2005-07-26 Brantford Chemicals Inc. 1,3-oxathiolan-5-ones useful in the production of antiviral nucleoside analogues
CN102911166B (zh) * 2001-03-01 2016-08-17 基利得科学公司 顺-ftc的多晶型物及其它晶型
ES2308136T3 (es) * 2003-01-14 2008-12-01 Gilead Sciences, Inc. Composiciones y procedimientos para la politerapia antiviral.
WO2005074654A2 (en) * 2004-02-03 2005-08-18 Emory University Methods to manufacture 1,3-dioxolane nucleosides
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
AU9125991A (en) * 1990-12-05 1992-07-08 University Of Georgia Research Foundation, Inc., The Enantiomerically pure beta -l-(-)-1,3-oxathiolane nucleosides
ZA923640B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9116601D0 (en) * 1991-08-01 1991-09-18 Iaf Biochem Int 1,3-oxathiolane nucleoside analogues
US5332814A (en) * 1991-11-12 1994-07-26 Ciba-Geigy Corporation Process for the preparation of carbacyclic nucleosides, and intermediates

Also Published As

Publication number Publication date
ES2139744T3 (es) 2000-02-16
CN1110479A (zh) 1995-10-18
EP0654031A1 (en) 1995-05-24
KR100304072B1 (ko) 2001-11-22
HU219199B (en) 2001-03-28
JPH08505643A (ja) 1996-06-18
HU9500364D0 (en) 1995-05-29
CN1046720C (zh) 1999-11-24
DE69422374T2 (de) 2000-06-29
OA10349A (en) 2001-10-18
BR9405423A (pt) 1999-05-25
PL180870B1 (pl) 2001-04-30
HK1008673A1 (en) 1999-05-14
RU95108553A (ru) 1996-11-20
DE69422374D1 (de) 2000-02-03
ATE188215T1 (de) 2000-01-15
HUT73630A (en) 1996-08-28
AU668829B2 (en) 1996-05-16
DK0654031T3 (da) 2000-06-13
US5763606A (en) 1998-06-09
GB9311709D0 (en) 1993-07-21
FI112078B (fi) 2003-10-31
CA2141029A1 (en) 1994-12-22
NO303449B1 (no) 1998-07-13
WO1994029301A1 (en) 1994-12-22
FI950535A (fi) 1995-02-07
NZ267379A (en) 1997-04-24
CA2141029C (en) 2000-07-25
EP0654031B1 (en) 1999-12-29
RU2139870C1 (ru) 1999-10-20
NO950432L (no) 1995-03-13
AU6966794A (en) 1995-01-03
PL307350A1 (en) 1995-05-15
JP3110461B2 (ja) 2000-11-20
FI950535A0 (fi) 1995-02-07

Similar Documents

Publication Publication Date Title
TW262474B (no)
NZ237132A (en) Preparation of substituted oxetanones from beta-hydroxy-omega-lactones; various beta-hydroxy and beta-keto-omega-lactones
NO950432D0 (no) Stereoselektiv syntese av nukleosidanaloger ved anvendelse av bicykliske mellomprodukter
Prugh et al. Methyl 3-0-benzyl-2, 4, 6-trideoxy-6-iodo-α-d-erythro-hexopyranoside, a chiral synthon for the synthesis of inhibitors of HMG-CoA reductase
SE9101482D0 (sv) Foerfarande foer framstaellning av mellanprodukter anvaendbara foer syntes av bensotiazepiner
HU209977B (en) Process for preparing fluorinated bis(hydroxymethyl)-cyclobutyl purines and pyrimidines, and pharmateutical preparations containing them
KR910006288A (ko) 신규 제조방법
CA2138018A1 (en) Process and Intermediates for Bis-Aza-Bicyclic Anxiolytic Agents
DE69717653D1 (de) Verfahren zur herstellung von glycidylethern
ATE207908T1 (de) Verfahren zur herstellung von 2-alkoxy-6- (trifluormethyl)-pyrimidin-4-ol
EP0393611A3 (en) Novel process for producing oxetanocin g
ATE132864T1 (de) Herstellung von dioxolanderivaten
HUT62867A (en) Process for producing uracyl derivatives
KR970042487A (ko) 알칼리 금속을 촉매로 이용한 아크릴산 에스테르 화합물의 제조방법
HUT36094A (en) Process for producing 4-quinolinones